Cronos Group (TSX:CRON) YoY EBITDA Growth : 34.85% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Cronos Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cronos Group's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 34.85%.

Cronos Group's EBITDA per Share for the three months ended in Mar. 2024 was C$-0.04.

Cronos Group YoY EBITDA Growth Historical Data

The historical data trend for Cronos Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cronos Group YoY EBITDA Growth Chart

Cronos Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

3,161.22

-105.36

-115.35

36.61

23.10

Cronos Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															26.67	5.88	21.69	31.03	34.85

Cronos Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cronos Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.253	-	-0.329)	/	\| -0.329 \|
=	23.10 %

Cronos Group's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(-0.043	-	-0.066)	/	\| -0.066 \|
=	34.85 %

Cronos Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cronos Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cronos Group (TSX:CRON) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cronos Group Inc (TSX:CRON) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CRON:USA 7CI:Germany

Address

111 Peter Street, Suite 300, Toronto, ON, CAN, M5V 2H1

Website

https://www.thecronosgroup.com

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

Executives

Michael Ernest Coates

Director